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Abstract
Objective: To systematically identify and appraise evidence on associations between psychological factors (moods,
beliefs, personality) and Health-related QoL (HRQoL) and/or global QoL in patients with Amyotrophic Lateral
Sclerosis (ALS).
Methods: A systematic review was conducted in several online databases (PsycINFO, EMBASE, PubMed and
CINAHL) up to October 2015. Articles were included if they reported associations between psychological factors (moods,
beliefs and personality) and HRQoL and/or global QoL in an ALS population. The search was limited to empirical studies,
published in English, which provided quantitative data. The methodological quality of the included articles was assessed.
Results: In total, 22 studies were included. Mood was investigated in 14 studies, beliefs in 11 studies and personality
in one study. Fifteen different psychological factors were extracted and assessed using 24 different measures. Twelve
different QoL measures were used in the selected studies, subdivided into seven different HRQoL measures and five
different global QoL measures. Higher levels of anxiety and depression appeared to be related to a poorer HRQoL,
whereas a higher level of religiosity seemed to be associated with better global QoL. No conclusive associations were
found for confusion-bewilderment (mood), spirituality, mindfulness, coping styles, hopelessness, perception of burden,
cognitive appraisal (beliefs), neuroticism, extraversion, openness, agreeableness and conscientiousness (personality), due
to insufficient or inconsistent evidence. Religiosity and spirituality appeared to become more positively associated
over time.
Conclusions: Our results suggest that higher levels of anxiety and depression are related to a poorer HRQoL,
whereas higher levels of religiosity appeared to be related to better global QoL. Associations might change
during the disease course. This review supports the importance of psychological factors with regard to ALS care.
Further research is needed to supplement the available evidence and to investigate how psychological factors
can be modified to improve QoL.
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Background
Amyotrophic Lateral Sclerosis (ALS) is a fatal, progres-
sive, neurodegenerative disorder affecting motor neurons
in the spinal cord, brainstem and motor cortex. Patients
suffer progressive wasting and weakness of limb, bulbar
and respiratory muscles, leading to inability to speak and
swallow, respiratory failure and complete paralysis [1, 2].
Currently, there is increasing awareness that ALS is also
associated with non-motor findings, including behavioral
and cognitive deficits [3, 4]. Patients eventually die due
to respiratory failure within three to five years after
symptom onset [1]. The incidence of ALS shows little
variation in Western countries, ranging from 1.5 to 2.7
per 100,000 person-years, [5] with an estimated lifetime
risk of 1 in 400 [6]. To date, no curative treatment is avail-
able. Therefore, optimal treatment is based on symptom
management and optimizing Quality of Life (QoL).
There is, as yet, no agreed-upon definition of QoL.
The World Health Organization (WHO) defines QoL as
‘a broad ranging concept affected in a complex way by
the person’s physical health, psychological state, level of
independence, social relationships and their relationship
to salient features of their environment’ [7]. Burns et al.
[8] have suggested that a distinction can be made
between Health-related QoL (HRQoL) and global QoL
in patients with ALS. Health-related QoL (HRQoL) is
more narrowly defined than global QoL and seeks to
address those aspects of self-perceived well-being that
are related to or affected by the presence of disease or
treatment [8]. Assessment of HRQoL typically includes
physical, psychological and social domains. Each domain
may include measures that assess the patient’s percep-
tion of symptoms, ability to function and disability [9].
Global QoL reflects overall QoL as judged by the patient
and takes into account other, non-medical concepts,
such as family, support system and friends [8]. Assessing
global QoL generally provides a broader picture of the
impact of disease on an individual’s life [9].
HRQoL declines during the course of the disease [10].
This is expected as HRQoL instruments are heavily
weighted toward physical function, and thus inevitably
decline over time as patients with ALS lose their abilities.
In contrast, there is growing evidence that global QoL
seems to remain at a stable level, even in patients with
advanced ALS. Psychological processes like coping,
reframing expectations and spiritual practice might
contribute to a change in internal standards and values of
QoL, ultimately resulting in unexpectedly high QoL, even
in later disease stages [11, 12]. QoL in patients with ALS
seems to be determined more by psychological, existential
and support factors than by physical health [13–16], im-
plying that a broad range of factors is involved in adjusting
to illness. Psychological factors in patients with ALS may
be modifiable targets for interventions to improve QoL.
The impact of psychological factors such as neuroti-
cism, coping, cognitive appraisals and mood on QoL
has already been demonstrated in other chronic diseases
[17, 18] and in other progressive neurological illnesses,
such as Huntington’s disease, Parkinson’s disease and
multiple sclerosis [19]. Differences have, however, been
reported between these progressive neurological illnesses
and ALS concerning the contribution of psychological
factors to QoL [19], suggesting that the rapidly progressive
disabling process of ALS requires a different psychological
adaptation process.
Over the last decade, interest has grown in the
relationships between psychological factors and QoL in
patients with ALS and to date, three narrative reviews
on this subject have appeared [20–22]. The authors
summarized associations between QoL and depression
[20, 21], anxiety [20], spiritual and existential issues
[20–22], sense of burden [22] and hope/hopelessness
[20, 22] in patients with ALS, but as they did not quantify
or appraise them, the relationships remain unclear.
The present study aims to collect and appraise the avail-
able evidence on the associations between psychological
factors and HRQoL and/or global QoL. Understanding
the relationships between QoL and psychological factors
and the contribution of these factors to either HRQoL or
global QoL might help health professionals to develop
adequate interventions in order to optimize QoL in
patients with ALS.
Methods
This study was registered followed the PRISMA




A search of online databases EMBASE, PsychINFO,
PubMed and CINAHL was carried out up to October,
2015. No constraint was placed on the year of publication.
The following MeSH headings and key words were used:
‘amyotrophic lateral sclerosis’ or ‘motor neuron disease’ in
combination with ‘psychological factors’ (and synonyms
including related terms, e.g. anxiety, depression, coping,
religiosity and neuroticism) and ‘quality of life’ (and
synonyms including related terms, e.g. well-being, value of
life and perceived health). Additional file 2 provides an
overview of the search strategy used in PubMed. Two
authors (AvG, CS) independently checked the titles and
abstracts on the selection criteria shown below, and com-
pared their results. Concurrence between both researchers
was calculated using Cohen’s kappa [23]. At each step of
the process, disagreement regarding selection was dis-
cussed and settled with reference to the explicit inclusion
criteria. If, after discussion, no agreement could be reached,
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another author (JV) was consulted for a final judgment.
The same procedure was followed for final in—or exclusion
after reading full text articles. The reference sections of
retrieved articles were searched to identify further studies
suitable for inclusion.
Quality assessment
After the study selection, methodological quality was
assessed independently by two researchers (AvG, EK)
according to an 8-point checklist, resulting in a score
that ranged from lowest quality (1) to highest quality
(8) [17]. The level of agreement between the researchers’
ratings was established using the Intraclass Correlation
Coefficient (ICC).
Eligibility criteria and operationalization of concepts
The current review is restricted to empirical studies which
provided quantitative data, thus excluding qualitative
studies, reviews and case reports. Only studies of patients
with ALS or providing separate data from patients with
ALS were included, in which standardized measures were
used to assess direct relationships between psychological
factors (determinant) and a total QoL construct (out-
come). Studies using a total score for HRQoL and global
QoL, or a mental or physical component score of the
HRQOL and / or a single-item score representing global
QoL, were included. Thus studies describing associations
between psychological factors and one subscale of a QoL
measure were not taken into account. Furthermore, the
review was limited to studies written in the English
language that were published in peer-reviewed journals.
Psychological factors are part of the contextual factors
(personal and environmental factors) defined by the
International Classification of Disability, Functioning
and Health (ICF) [24]. Psychological factors, such as
coping styles, may play a role in disability at any level,
but are not part of a health condition or health states
[24]. In order to gain more insight into their association
with HRQoL and/or global QoL, we have clustered the
psychological factors into three main groups: mood,
beliefs and personality. Mood is a generalized, internal
state of feeling (e.g. anxiety, depression and anger) and is
closely related to the concepts of affect and emotion.
Beliefs refer to people’s perceptions of reality including
perceptions of health or illness and one’s ability to cope
with illness (e.g. attitudes, appraisals, religiosity and cop-
ing strategies). Personality can be defined as a dynamic
and organized set of characteristics which a person pos-
sesses and which uniquely influence his or her beliefs,
motivations and behaviour in various situations [25].
Data extraction and analysis
We collected information on study characteristics:
author, country, sample size and study design, and
patient characteristics: age at inclusion, the time of
assessment since ALS onset, the functional status of
patients (using the Amyotrophic Lateral Sclerosis
Functional Rating Scale (ALSFRS), the diagnostic cri-
teria and the type of ALS onset (spinal vs. bulbar).
Furthermore, measures of global QoL and HRQoL and of
psychological factors, as well as associations between
psychological factors and QoL (Health-related and global)
were extracted.
Bivariate and multivariate associations were described
separately in terms of correlation coefficients (r), standard-
ized β-coefficients (β) and the explained variance of the
psychological factors (R2). The strength of correlation was
described as follows: “weak” correlation = 0 < ∣r∣ < 0.3;
“moderate” correlation 0.3 < ∣r∣ < 0.5; “strong” correlation
∣r∣ > 0.5 (Cohen, [23]). We classified the methodological
quality of the studies to be “high” if they were above 5.5,
“adequate” between 3.5 and 5.5, and “poor” below 3.5.
Psychological factors were considered “consistent re-
lated” if (1) the majority (>50 %) of all studies reported
statistically significant bivariate and/or multivariate asso-
ciations; (2) the majority of the bivariate associations
were moderate or strong; and (3) the methodological
quality of these studies was adequate or high.
Results
Description of studies included
The search strategy produced a total of 1040 articles
(Fig. 1). After removing 153 duplicates, a further 830
articles were removed after screening title and abstract.
Agreement on selection of titles and abstracts between
the two raters was high (Cohen’s kappa 0.82). A total of
57 articles remained for full-text screening; 22 articles
met all inclusion criteria. The screening of reference
lists produced one additional article [10]. In two studies
[16, 26], the same cohort data was used; we included
the study by Bremer because of a higher quality
assessment.
The characteristics of the 22 included studies are pre-
sented in Table 1. Studies were published between 1999
and 2015; most were cross-sectional (n = 16); six used lon-
gitudinal data [16, 27–31]. The median sample size was
n = 49 (range 26–197). Studies concerned patients with a
mean time of ALS onset between 11.7 months and
5.7 years; the disease severity ranged from 17.4 (severely
impaired) to 35.1 points (moderately impaired). The mean
age at inclusion varied between 55.3 and 64.0 years; a mi-
nority of the patients (7-33 %) had a bulbar onset of ALS,
and there was a slight male predominance (M:F ratio ~
1.5:1). These findings were consistent with those of the
general ALS population (mean age 58–63 years; bulbar
onset of 30 % and M:F ratio ~ 1.2–1.5:1) [32, 33].
Across the studies, fifteen different psychological
factors were assessed using 24 different measures. The
van Groenestijn et al. Health and Quality of Life Outcomes  (2016) 14:107 Page 3 of 20
various instruments for assessing psychological factors
are described in Table 2. Mood was investigated in 14
studies, beliefs in 11 and personality in one study. Two
ALS-specific questionnaires, the ALS Depression
Inventory (ADI-12) [34] and the Motor Neuron Disease
Coping Scale (MNDCS) [35] were applied in one [28]
and three [30, 36, 37] studies, respectively. The modi-
fied versions of the Hospital Anxiety and Depression
Scale (HADS), which were intended not to rely on
measuring the physical components of depression, were
used in two studies [37, 38] (Table 2).
A total of 12 different QoL measures were used in the
selected studies, including five different Global QoL
measures and seven different Health-related QoL mea-
sures (Table 3 and Table 4, resp.). One ALS-specific
HRQoL questionnaire, the Sickness Impact Profile ALS
(SIP/ALS-19) [39], was used in two studies [14, 31].
The average methodological quality score of the stud-
ies was 5.3 and ranged from 3 to 8 out of a maximum 8
points (Table 5). Seven studies (32 %) achieved a “high
quality” score (≥6/8). Inter-rater agreement on quality of
the individual studies was high (ICC = 0.90).
Psychological factors associated with QoL in ALS
An overview of the bivariate and multivariate associations
between psychological factors and QoL is presented in
Table 6. Due to the heterogeneity of instruments used in
assessing both psychological factors (n = 24) and QoL
(n = 12), a meta-analysis was not possible.
Mood associated with QoL
Concerning mood, relationships between QoL and anxiety,
depression and confusion-bewilderment were found.
Anxiety
Six studies assessed the relationship between anxiety
and QoL [15, 19, 37, 38, 40, 41]; three studies reported
HRQoL and three global QoL.
Two out of three studies, including one high quality




















Removed after screening title/abstract (830)
Removed because of the same cohort data (1)
Added after screening references (1)
Total
(1040)
Removed after screening full-text (35)
- Subjects not exclusively ALS patients (2)
- Outcome not HRQoL or global QoL (5)
- Outcome is subscale, not a total QoL construct (5)
- No determinant-outcome relationships reported (10)
- Qualitative study / QoL measured with interviews (4)
- Psychological factor is clustered (2)
- Intervention study (1)
- Validity study (1)
- No original study; conference abstract (5)
Fig. 1 Search flowchart
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Table 1 Patient and study characteristics
Study characteristics Patient characteristics
Author (date) Country of research Sample size
n (male n)
Design Age in years Time since onset (O)/





Bremer (2004)T0 [16] U.S.A 49 (29) Longitudinal 57.8 (13.0) 34.9 (13.2) moO 27.9 (6.3) El Escorial n.m
Chio (2004) [13] Italy 80 (49) Cross sectional 59.8 (12.6; 26–81) 2.1 (1.7; 1–7.8) yrO 26.6 (9.5; 3–38) El Escorial n.m.
Clarke (2001) [15] Ireland 26 (18) Cross sectional 63M (34–86) 31.5 (4–156)M moD 22.5M (11–36) El Escorial n.m
Dal Bello-Haas (2000) [47] U.S.A 60 (38) Cross sectional 56.2 (12.2) n.m n.m El Escorial n.m.
Ganzini (1999) [45] U.S.A. 100 (61) Cross sectional 54M (51.6–56.8) 2.8 (2.0–3.6)M yrD n.m n.m n.m
Gibbons (2013) [37] U.K. 147 (90) Cross sectional 61 (11; 35–81) n.m 22.3 (9.5; 4–48) ‘confirmed diagnosis’ n.m
Goldstein (2002) [38] U.K 31 (19) Cross sectional 64.0 (11.9) 15.9 (5.2) moD n.m El Escorial n.m
Ilse (2015) [10] Germany 49 (25) Cross sectional 63.8 (10.0) 35.1 (36.3) moO 32.6 (9.2) R El Escorial 33 %
Krampe (2008)T0 [27] Germany 31 (19) Longitudinal 60.3 (10.4; 32.9–79.7) 96.3 (70.5; 22.4–330.4) wkO 27.0 (6.6; 12–38) El Escorial 19 %
Lule (2008)T0 [28] Germany 39 (19) Longitudinal n.m 43.9 (37.5; 0–170) moD 19.9 (21.1; 0–39) El Escorial n.m
Matuz (2010) [36] Germany 27 (15) Cross sectional 55.3 (11.1; 35–73) 36 (4–129) moD 17.4 (9.8; 0–36) ‘by a neurologist’ 7 %
Matuz T0 (2015) [30] Germany 27 (15) Longitudinal 55.3 (11.1; 35–73) 43.2 (30.5; 4–129) moD 17.4 (9.8; 0–36) El Escorial 7 %
McCabe (2009) [19] Spain 120 (72) Cross sectional 63.2 (12.4) 5.7 (5.8)O yr n.m n.m n.m
Montel (2012) [46] France 49 (26) Cross sectional 63 (12) 45 (28) moO 28.2 (9.0)R El Escorial 22 %
Pagnini T0 (2015) [29] Italy USA 197 (115) Longitudinal a a 30.6(9.9)SA ‘self-declared’ n.m
Peric (2010) [40] Serbia 74 (45) Cross sectional 57 (11) 29 (27) moO 34 (8)R El Escorial n.m.
Pizzimenti (2013) [43] Italy 36 (22) Cross sectional 63.7 (10.9) 22 (14) moO 35.1 (8.7) El Escorial 22 %
Robbins (2001)T0 [31] U.S.A 60 (32) Longitudinal 58.5 (13.5; 27–83) n.m 28.1 (6.3; 12–39) El Escorial n.m
Simmons (2000) [14] U.S.A 96 (52) Cross sectional 57.8 (23–80) 31.8 (2 mo-10 year) moO 26.6 (9–39) ‘met the criteria’ n.m
Tramonti (2012) [42] Italy 40 (30) Cross sectional 59.1 (10.9; 34–84) n.m 20.8 (8.3; 7–36) n.m n.m
Vignola (2008)TD [41] Italy 29 (20) Cross sectional 63.6 (7.8; 44–78) 11.7 (23.7; 2–43) moO 33.1 (4.8; 22–39) El Escorial n.m
Winter (2010) [44] Germany 37 (21) Cross sectional 59.6 (11.0) 2.3 (1.9) yrO n.m El Escorial n.m
Note. Numbers are presented as means (SD; range), unless stated otherwise
Abbreviations: n.m not mentioned, M median instead of mean, yr year, mo months, wk weeks, ALSFRS Amyotrophic Lateral Sclerosis Functional Rating Scale, R ALSFRS-Revised, SA self-administered ALSFRS, T0 data from
baseline measurement, TD data from diagnostic phase, O onset, D diagnosis




















Table 2 Psychological factor measurements
Psychological factors Measurement and references Number
of items






Anxiety Hamilton rating scale for anxiety
(HAM-A)
Hamilton (1959) [63]
14 To assess the severity of symptoms of anxiety.
Each of the items contains a number of symptoms,
and each group of symptoms is rated on a scale.
5-point scale. Total scores for anxiety
range from 0 to 56.
Score interpretation:
<17: mild severity
18–24: mild to moderate severity
25–30: moderate to severe
Generic [40]
Hospital Anxiety and Depression
Scale subscale anxiety (HADS-a)
Zigmond (1983) [54]
7 To assess psychological distress in medically
ill patients. The instrument concentrates on the
psychic rather than the somatic symptoms of
mood disorder in order to provide an assessment
of mood independent of levels of physical
disability in patients with medical illnesses.
4-point scale. Total scores for anxiety
range from 0 to 21
Score interpretation:
≤7: non-cases
8–10: possible clinical levels of distress
11–21: clinical levels of distress
Generic [15, 38]
Hospital Anxiety and Depression
Scale subscale anxiety (HADS-a)—
modified version 1
Gibbons (2011) [56]
6 To assess psychological distress in medically ill
patients. The original HADS was modified with
removal of question 11 of the original HADS
“I feel restless as if I have to be on the move”.
4-point scale. Total scores for anxiety
range from 0 to 18.
Score interpretation:
Scores of 9–18: case level anxiety
ALS [37]
State and Trait Anxiety
Inventory (STAI)
Spielberger (1968) [64]
40 To assess trait and state anxiety.
STAIs: 20 items assess trait anxiety. STAIs is
defined as an unpleasant emotional arousal
in face of threatening demands or dangers;
STAIt: 20 items assess state anxiety. STAIt reflects
the existence of stable individual differences
in the tendency to respond with state anxiety
in the anticipation of treating situations.
These two parts differ in the item wording,
in the response format (intensity versus
frequency), and in the instructions given
for responses.
4-point scale. Total scores for anxiety






Depression Beck Depression Inventory (BDI)
Beck (1961) [53]
21 To assess severity of depressive symptoms. 4-point scale. Total scores for depression
range from 0 to 63.
Score interpretation:
0–9: no depressive symptoms
10–18: mild to moderate depressive symptoms
19–29: moderate to severe depression
30–63: severe depression




21 To assess patient’s level of depression.
The first 17 of the 21 items contribute to the total
score and items 18–21 give additional information,
not part of the scale, such as paranoia and
diurnal variation
8 items 5-point scale; 9 items 3-point scale.





19–22 = severe depression
23–50 = very severe depression
Generic [40]
Hospital Anxiety and Depression Scale
subscale depression (HADS-d)
Zigmond (1983) [65]
7 To assess psychological distress in medically ill
patients. The instrument concentrates on the
psychic rather than the somatic symptoms
of mood disorder in order to provide
an assessment of mood independent
4-point scale. Total scores for depression
range from 0 to 21.
Score interpretation:
≤7: non-cases
8–10: possible clinical levels of distress





















Table 2 Psychological factor measurements (Continued)
of levels of physical disability in patients
with medical illnesses.
Hospital Anxiety and Depression
Scale subscale depression
(HADS-d) - modified version 2
Abrahams (1997) [66]
6 To assess psychological distress in medically
ill patients. The original HADS was modified
with removal of question 8: “I feel slowed down”,
as it was felt likely that this would falsely exaggerate
the measure of depression due to the physical
symptoms of ALS.
4-point scale. Total scores for depression
range from 0 to 18.
Score interpretation:
≤7: non-cases
8–10: possible clinical levels of distress
11–21: clinical levels of distress
ALS [38]
Hospital Anxiety and Depression
Scale subscale depression
(HADS-d) - modified version 1
Gibbons (2011) [56]
6 To assess psychological distress in medically ill
patients. The original HADS was modified with
removal of question 8: “I feel slowed down”.
4-point scale. Total scores for depression
range from 0 to 16 (Two items in the
depression subscale were recorded 0-1-1–2).
Score interpretation:





9 To assess a major depressive disorder. Score interpretation:
5 out of 9 symptoms have to be present and
represent a change from previous functioning;
at least one of the symptoms is either (1)




12 To assess depressive symptoms, specifically
developed for ALS patients and addresses
depressive symptoms excluding increasing
physical impairments commensurate with ALS.
4-point scale. Total scores for depression
range from 12 to 48.
Score interpretation:
<22: absence of depression
22–28: mild depression
>28: clinically relevant depression
ALS [28]
Zung Depression Scale (ZDS);
Zung (1965) [68] also called
Zung Self-Rating Depression Scale
(SDS) (1965)
20 To assess depression 4-point scale. Total scores for depression






Mood Profile of Mood State short-form
(POMS-SF) McNair (1992) [69]
37 To assess six states of mood: tension-anxiety,
depression-dejection, anger-hostility, vigour-
activity, fatigue-inertia, and confusion-bewilderment.
Abbreviated 37-item version of the original scale
using the 5-point Likert Scale; 0 (not at all) to 4
(extremely). Total mood disturbance (TMD): sum
of the subscales.
Score interpretation:
Higher scores reflect higher presence of the
mood state.
Generic [19]
Religiosity Idler Index of Religiosity (IRR)
Idler (1987) [70]
4 To assess the level of religiosity. It addresses
both public and private aspects of religiosity:
Public religiosity (IIR-Pu) (2 items): frequency of
church attendance and number of church members
known personally
Private religiosity (IIR-Pr) (2 items) how religious
they perceived themselves to be and the amount
of strength and comfort obtained from religious
practices.
Public religiousness: 1-item, 6-point scale; 1-item,
4-point scale
Private religiousness: 1-item, 4- point scale; 1-item,
3-point scale
The religiosity scores are summed to produce public,
private, and total religiosity; scores range from 2–10,
2–7 and 4–17, respectively.
Score interpretation:
Higher scores indicate higher level of religiosity.
Generic [13, 14,
16, 31]
Spirituality Spiritual Well-being Scale (SWBS) (1)
Reed (1987) [71]
10 To assess the level of spiritual well-being. 6-point scale. Total scores of spiritual well-being
range from 6 to 36.
Score interpretation:





















Table 2 Psychological factor measurements (Continued)
Spiritual Well-being Scale (SWBS) (2)
Ellison (1983) [72]
20 The scale consists of 10 religious well-being items
(RWB) and 10 existential well-being items (EWB);
spiritual well-being.
6-point scale. Total scores (RWB + EWB) of spiritual
well-being range from 20 to 120.
Score interpretation:
Higher scores indicate higher spiritual well-being.
Generic [47]
Mindfulness Langer mindfulness scale (LMS)
Pirson (2012) [73]
14 Three domains associated with mindful thinking:
novelty seeking, engagement and novelty producing.
Total scores range from 14–98,
Score interpretation:
Higher scores reflect higher mindfulness
Generic [29]
Hopelessness Becks Hopelessness Scale (BHS)
Beck (1974) [74]
20 To assess three major aspects of hopelessness: feelings
about the future, loss of motivation, and expectations.
2-point scale. Total scores of hopelessness









Zarit Burden Inventory (ZBI) – revised
Zarit (1980) [75]
3 Three items of the original ZBI were revised to measure
patient beliefs that their medical condition stressed,
burdened, or caused financial hardship to their family.
5-point scale. Total score of perception
of burden to others (1 item) range
from 0 to 4.
Score interpretation:
Higher score indicates higher perception
of burden to their family.
ALS [45]
Cognitive appraisal Appraisal scale
Smith (1993) [76]
4 To assess patients’ primary (motivational relevance,
motivational congruence) and secondary appraisal
(problem-focused and emotion-focused coping potential)
9-point scale. Scores per item range
from 1 to 9.
Total scores are not mentioned.
Score interpretation:
The larger the difference between the
two items of primary appraisal (motivational
relevance and motivational congruence), the
more patients feel threatened by the disease.
Generic [30, 36]
Coping Motor Neuron Disease Coping Scale
(MNDCS) – adapted version 1
Lee (2001) [35]
18 To assess extent to which patients relied on the
coping strategies.
18 questions of the original 22-item scale were
assigned to 6 subscales.
6-point scale. Total score for each type of
coping was obtained by generating the
mean score of the grouped
scales. Ranges of total scores are not mentioned.
Score interpretation:
Higher score reflects greater use of the coping
strategy.
ALS [30, 36]
Motor Neuron Disease Coping Scale
(MNDCS/Cope-MND)—adapted version 2
Lee (2001) [35]
9 To assess extent to which patients relied on the
coping strategies.
The original MNDCS was reduced to a 9-item scale.
6-point scale. Ranges of total scores are not
mentioned.
Score interpretation:





28 Measures 14 dimensions of coping: distraction; active
coping; denial; emotional support; instrumental support;
disengagement; venting; positive reframing; planning;
acceptance; humour; religion; self-blame; substance use.
Each dimension consists of 2 items.
4-point scale. No overall score. Score range per
dimension ranges from 2 to 8, per item from
1 to 4.
Score interpretation:
Higher score reflects greater use of the coping
strategy.
Generic [46]
Personality traits NEO Five Factor Inventory (NEO-FFI)
Costa (1992) [78]
60 To assess the five dimensions of personality, postulated
by the five-factor model of personality: neuroticism,
extraversion, openness, agreeableness, and conscientiousness.
5-point scale. Each of the five-factor subscales
consists of 12 items, resulting in mean factor
scores ranging from 0 to 4.
Score interpretation:





















significant relationships with HRQoL; anxiety was
strongly (−0.53) negatively associated with HRQoL. A
similar contribution was obtained from multivariate
analyses [19]. In contrast, one high quality study
failed to find any relationship between anxiety and
HRQoL [40].
Significant negative associations with global QoL were
found in one out of three studies [41]. More specifically,
low trait and state anxiety was associated with higher
global QoL and was found in the diagnostic as well as
the follow-up phase [41]. Two studies, of which one
used a modified HADS, did not find any significant asso-
ciations with global QoL [15, 19].
Depression
In total, fourteen studies assessed depression in relation to
QoL [10, 13, 15, 19, 27, 28, 37, 38, 40–45]. Eight studies
reported associations with HRQoL and eight studies with
global QoL. Two studies reported both HRQoL and global
QoL outcomes.
A significantly negative association with depression
and HRQoL was reported in seven out of eight studies,
including two of high quality, of which one used a modi-
fied HADS. Depression was moderately to strongly
(−0.430; −0.60; −0.617) [10, 37, 42] correlated with
HRQoL [10, 27, 42–44]. The contribution of depressive
symptoms to HRQoL was also endorsed in regression
analysis [19, 27, 37, 43, 44]. A single study of high
quality failed, however, to find a significant association
with depression and HRQoL in bivariate correlations
[40]. Another study used four different HRQoL mea-
sures and found two out of four significant associations
between depression and HRQoL in bivariate and multi-
variate analysis [44].
A significantly negative association with depression
and Global QoL was reported in four out of eight







The Schedule for the Evaluation of
Quality of Life (SEIQoL)
McGee (1991) [79]
O’Boyle (1992) [80]
46 SEIQoL assesses overall subjective QoL as judged by the patient in healthy
or ill individuals. It is derived from a decision analysis technique known as
judgement analysis, administered through a semi-structured interview. Patients
rate their satisfaction with areas of their life by assessing three aspects of QoL.
The patients have to 1) nominate the life areas (cues) which are important to
their QoL; 2) rate their current level of functioning in each of these salient areas;
and 3) rate the relative importance of each of their chosen cues.
SEIQoL index score: the SEIQoL scores are entirely person-specific, for the
purpose of group analyses an overall global or index QoL score (also referred
to as a total QoL score) is calculated. The resulting SEIQoL index ranges from 0
(worst possible QoL) to 100 (best possible QoL).
[15, 42]
The Schedule for the evaluation of
Quality of Life-Direct Weighting
(SEIQoL-DW)
Hickey (1996) [81]
15 SEIQoL-DW is a shorter, direct-weight (DW) version of the SEIQoL, employs
an alternative method of deriving cue weights using a colored disk.
SEIQoL-DW index score: The SEIQoL-DW scores are entirely person-specific;
for the purpose of group analyses an overall global or index QoL score
(also referred to as a total QoL score) is calculated. The resulting SEIQoL
index ranges from 0 (worst possible QoL) to 100 (best possible QoL).
[13, 28, 30, 38]
The McGill Quality of Life Questionnaire
(MQOL)
Cohen SR (1995/1996) [82, 83]
17 MQOL assesses overall subjective QoL as judged by the patient. Subjects
evaluate their lives over the past 2 days on five subscales using a 10-point
semantic-differential format. Originally designed for cancer and HIV patients.
It is not heavily weighted toward physical function and it includes an
existential element.
MQOL includes five domains, two of which are health-related: Physical
Symptoms (MQOL-Ph) (3 items) and Physical Well-being (MQOL-PW)
(1 item); and three are non-health related: Psychological symptoms
(MQOL-Ps) (4 item); Existential Well-being (MQOL-EW) (6 items) and
Social Support (MQOL-Su) (2 items). Scores on the subscales range
from 0 (worst) to 10 (best). The MQOL total score is the mean of the
5 subscales, score ranges from 0 (worst QoL) to 10 (best QoL).
MQOL-SIS: besides the subscales there is also a Single-Item Score (SIS):
the patient is asked to indicate his/her self-perceived overall QoL in the
past two days in a single-item scale (SIS) measuring overall subjective
QoL, rated from 0 (very bad) to 10 (excellent).
[13, 14, 16, 27,
29, 41]
QoL-single-item question
Self-developed by Ganzini (1999) [45]
1 A single-item question to assess patients self-perceived overall QoL.
End-points labelled 1 = “my quality of life is as good as it can be”
and 6 = “my quality of life is very bad, horrible”.
[45]
QoL-single-item question
Self-developed by Krampe (2008) [27]
1 A single-item question to assess patients self-perceived overall QoL.
“Over the past seven days, the quality of my life has been”: very
poor (0) – excellent (10).
[27]
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studies, in both bivariate and multivariate analysis
[13, 27, 28, 41]. Depression was moderately (−0.36)
[28] negatively associated with global QoL. In four
other studies, however, including 2 which used ALS-
specific questionnaires, no significant correlations be-
tween depression and global QoL were demonstrated
[15, 38, 42, 45].
A prospective long-term follow-up study reported the
relationship between depression and HRQoL and global
QoL during the first year after baseline measurement.
Patients who were more depressed had lower HRQoL
and global QoL scores at month 1 and during a 12-
month follow-up. The results of a linear mixed model
analysis showed no interaction effect between depression
and time, indicating that more depressed patients did
not differ from less depressed patients as far as the
trajectories of Global QoL and HRQoL were con-
cerned [27].
Confusion-bewilderment
One study examined the relation between ‘confu-
sion—bewilderment’ and QoL. In regression analysis,
this mood state made a significant positive contribu-
tion to HRQoL (β = 0.33) [19].
Beliefs associated with QoL
With regard to beliefs, relationships between QoL and re-
ligiosity, spirituality, mindfulness, coping, hopelessness,
perception of burden and cognitive appraisal were found.











36 SF-36 is a standardised, generic health-related quality of life measure. It consists
of 36 items covering 8 dimensions. Each dimension is transformed into a 0–100
scale on the assumption that each question carries equal weight. High scores
indicate good QoL. Four of these dimensions (limitations in physical functioning
(PF); role limitations due to physical health problems (RP), bodily pain (BP), and
general health perceptions (GH)) are summarized in the Physical Component
Score (PCS), and four others (vitality (VT); social functioning (SF), role limitations
due to emotional problems (ER), general mental health (MH)), in the Mental
Component Score (MCS).
[40, 44, 46]
Sickness Impact Profile (SIP)
Bergner (1981) [84]
136 SIP measures physical, mental and social aspects of health-related functioning;
it contains statements regarding behaviour “sickness impact” and the individual
is asked to respond by checking items that describe their health status. SIP contains
136 items in 12 categories and two dimensions (physical and psychosocial). Overall,
category and dimension scores may be calculated from 0—100 (best).
[47]
Sickness Impact Profile (SIP/ALS-19)
McQuire (1997) [39]
19 SIP/ALS-19 assess health-related QoL. It is a questionnaire consisting of 19 items
from the full SIP (Sickness Impact Profile) believed to have the greatest impact on
QoL, based on opinions of ALS clinical specialists. Extracted from the full SIP total




5 EuroQoL-5D assess health-related QoL. It consists of five questions that relate to
five dimensions of health: mobility, self-care. usual activities, pain/discomfort,
anxiety/depression. Each dimension is divided into three levels of severity (1,




1 EQ VAS assess health-related QoL. It is a visual analogue scale (VAS thermometer
type) to rate patients current HRQoL ranging from 0 (worse imaginable health state)
to 100 (best imaginable health state).
[44]
World Health Organization
Quality of Life brief questionnaire
(WHOQoL-BREF)
Skevington (2004) [87]
26 WHOQoL-BREF assesses quality of life within the context of an individual’s culture,
value systems, personal goals, standards and concerns. Generic instrument, measures
QoL of life across 4 domains: physical health (7 items), psychological health (6 items),
social relationships (3 items) and environment (8 items). Domain scores can be
transformed to total scores from 0 (worse imaginable health state) to 100 (best
imaginable health state). Two other items measure overall QoL and general health.
Items are rated on a 5-point scale (low score of 1 to high score of 5) to determine
a raw item score. Subsequently, the mean score for each domain is calculated, resulting
in a mean score per domain that is between 4 and 20. Finally, this mean domain score
is then multiplied by 4 in order to transform the domain score into a scaled score, with
a higher score indicating a higher QoL.
[19, 37]
Quality of Life Index (QL-Index)
Spitzer 1981 [88]
5 The Spitzer Qol Index (SQLI/ QLI/ QL-Index) assesses health-related QoL in palliative
care populations. It covers five dimensions of quality of life: activity, daily living, health,
support of family and friends, and outlook on life. Each dimension is rated on a
three-point Likert scale (0 to 2), with the range of scores from 0 to 10. Lower scores
reflect a higher QoL.
[43]
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Religiosity
Five studies assessed the relationship between religiosity
and QoL [13, 14, 16, 31, 46]: three of these reported
HRQoL, four global QoL and two studies both HRQoL
and global QoL outcomes.
Two out of three studies did not find any significant
relationships between religiosity and HRQoL [14, 46].
Regression analyses of a third study, which was of high
quality, [31] revealed that a high level of religiosity made a
significant positive contribution to HRQoL at 6 months’
follow-up, but not at the earlier assessment (3 months’
follow-up).
Three out of four studies [13, 14, 16] showed that a
higher level of religiosity was significantly related to higher
global QoL. Both ‘religiosity’ and ‘private religiosity’ (how
religious patients perceived themselves to be and the
amount of strength and comfort obtained from religious
practices) developed a significant, moderate to strong
association with global QoL over time (3–16 months’ and
6–16 months’ follow-up, respectively) [16]. Regression
analysis confirmed this increasing relationship between
‘private religiosity’ and global QoL with time and showed
an increase in explained variance of 16 % at 12 months'
follow-up [16]. On the other hand, one high quality study
did not find any significant associations with religiosity
and global QoL at 3 or 6 months’ follow-up [31].
Spirituality
Two studies tested the correlation between spirituality
and QoL [16, 47]. One used an HRQoL measure [47],
whereas the other a global QoL measure [16].
The first study [47] split spiritual well-being along
the dimensions of religious well-being (which refers
to a relationship with God or what is understood as a
spiritual being) and existential well-being (which
involves a sense of purpose and meaning in life as a
means of feeling connected to the world, separate
from any specifically religious reference, beliefs and
needs). Existential well-being was not associated with
HRQoL. In contrast, religious well-being was strongly
associated (−0.99) with higher HRQoL, independent
of the clinical phase of ALS.
















Bremer [16] 2004 1 1 1 1 0 0 0 1 5.0
Chio [13] 2004 1 0.5 1 1 0 0 1 1 5.5
Clarke [15] 2001 1 1 1 1 0 0 0 1 5.0
Dal-Bello-Haas [47] 2000 1 0 0.5 1 0 0 0 1 3.5
Ganzini [45] 1999 0 1 0.5 1 1 0 1 1 5.5
Gibbons [37] 2013 1 0 1 1 1 1 1 1 7.0
Goldstein [38] 2002 1 0 1 1 0 0 0 0 3.0
Ilse [10] 2015 1 0 1 1 0 0 0 1 4.0
Krampe [27] 2008 0 0 1 1 0 0 1 1 4.0
Lule [28] 2008 1 0 0.5 1 0 0 1 1 4.5
Matuz [36] 2010 1 0 1 1 0 1 1 1 6.0
Matuz [30] 2015 1 1 1 1 0 0 1 1 6.0
McCabe [19] 2009 1 0 0.5 1 1 0 1 1 5.5
Montel [46] 2012 1 0 1 1 0 0 0 1 4.0
Pagnini [29] 2015 1 0.5 0.5 1 1 0 1 1 6.5
Peric [40] 2010 1 0.5 1 1 0 1 1 1 6.5
Pizzimenti [43] 2013 1 1 1 1 1 1 1 1 8.0
Robbins [31] 2001 1 0.5 0.5 1 1 0 1 1 6.0
Simmons [14] 2000 1 0.5 1 1 0 0 0 1 4.5
Tramtoni [42] 2012 1 0 0.5 1 0 0 1 1 4.5
Vignola [41] 2008 1 0.5 1 1 0 0 1 1 5.5
Winter [44] 2010 1 0.5 0.5 1 0 0 1 1 5.0
Note. 1 = internal validity: use of validated and reliable measures, 2 = control of patient drop-out: including nonresponse analysis and describing executive patients,
3 = external validity: specifying in/exclusion criteria and demographic and disease characteristics (diagnosis, age, gender, site of ALS onset, time since diagnosis,
severity), 4 = statistical validity: testing for statistical significance, 5 = adequate sample size in relation to the number of determinants (univariate ratio 20:1 and
multivariate ratio 10:1), 6 = control for multicollinearity, 7 = control for potential confounding variables, 8 = clear description of main finding [17]
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Table 6 Results of the bivariate and multivariate associations between psychological factors and QoL in patients with ALS













Anxiety HAM-A HRQoL SF-36 total ns/nr [40] 6.5
HAM-A SF-36 PCS ns/nr
HAM-A SF-36 MCS ns/nr
HADS-a1 WHOQoL-BREF total −0.53** [37] 7.0
Anxiety - Tension POMS WHOQoL-BREF total nr β = −0.47* [19] 5.5
Anxiety HADS-a Global QoL SEIQoL index score ns/nr [15] 5.0
HADS-a SEIQoL-DW index score ns/nr [38] 3.0
State anxiety STAIsO MQOL total nr s**/nr [41] 5.5
STAIs MQOL total <1 mo after D. nr s**/nr
STAIs MQOL total >1 mo after D. nr s*/nr
Trait anxiety STAIt MQOL total <1 mo after D. nr s**/nr
STAIt MQOL total >1 mo after D. nr s* /nr
Depression
Depression—Dejection POMS HRQoL WHOQoL-BREF total nr β = −0.24* [19] 5.5
Depression HADS-d1 WHOQoL-BREF total −0.60** β = −0.41* [37] 7.0
HAM-D SF-36 total ns/nr [40] 6.5
HAM-D SF-36 PCS ns/nr
HAM-D SF-36 MCS ns/nr
ZDS SF-36 total −0.617** [42] 4.5
ZDS QL-Index s* /nr β = −0.08* [43] 8.0
BDI EQ-5D index score −0.430** [10] 4.0
BDIA SF-36 MCS nr β = −0.391** [44] 5.0
BDIA SF-36 PCS ns/nr
BDIA EQ-5D index score nr β = −0.272
BDIA EQ VAS nr β = −0.381*
BDI HRCS 1 mo F.U. nr s / nr [27] 4.0
BDI HRCS 12 mo F.U. nr s**/nr
Depression x time BDI HRCS over 12 mo nr ns
Depression ADI-12 Global QoL SEIQoL index score −0.36* [28] 4.5




















Table 6 Results of the bivariate and multivariate associations between psychological factors and QoL in patients with ALS (Continued)
ZDS SEIQoL-DW index score nr s*/nr [13] 5.5
ZDS MQOL Single Item Score nr s*/nr
ZDS SEIQoL index score −0.205 [42] 4.5
ZDSo MQOL total nr s**/nr [41] 5.5
HADS-d SEIQoL index score ns/nr [15] 5.0
HADS-d2 SEIQoL-DW index score ns/nr [38] 3.0
BDI Single-item-question4 1 mo F.U. nr s*/nr [27] 4.0
BDI Single-item-question4 12 mo F.U. nr s*/nr
Depression x time BDI Single item question4 over 12 mo nr ns
Confusion - Bewilderment POMS Global QoL WHOQoL-BREF total nr β = 0.33* [19] 5.5
BELIEFS Religiosity
Religiosity IIR-tot HRQoL SIP/ALS-19 total 0.169 [14] 4.5
IIR-tot SIP/ALS-19 total 3 mo F.U. nr ns / nr [31] 6.0
IIR-tot SIP/ALS-19 total 6 mo F.U. nr s***/nr
Religion - coping Brief COPE SF-36 PCS/SF-36 MCS −0.26P −0.01M [46] 4.0
Religiosity IIR-tot Global QoL MQOL total 0.15 [16] 5.0
IIR-tot MQOL total 3–4 mo F.U. 0.28
IIR-tot MQOL total 6–8 mo F.U. 0.37**
IIR-tot MQOL total 9–12 mo F.U. 0.33*
IIR-tot MQOL total 12–16 mo F.U. 0.46**
IIR-tot MQOL total 3 mo F.U. nr ns / nr [31] 6.0
IIR-tot MQOL total 6 mo F.U. nr ns / nr
IIR-tot MQOL total 0.221 [14] 4.5
IIR-tot MQOL Single Item Score 0.331**
Religiosity Private IIR-Pr MQOL total 0.13 β = 0.05; R2 = 0% [16] 5.0
IIR-Pr MQOL total 3–4 mo F.U. 0.42** β = 0.31**
IIR-Pr MQOL total 6–8 mo F.U. 0.49** β = 0.35**
IIR-Pr MQOL total 9–12 mo F.U. 0.34* β = 0.21
IIR-Pr MQOL total 12–16 mo F.U. 0.50** β = 0.41***; R2 = 16 %***
IIR-Pr SEIQoL-DW index score s*/nr [13] 5.5
Spirituality [16] 5.0
Existential well-being SWBS6 - EWB HRQoL SIP total ns/nr [47] 3.5




















Table 6 Results of the bivariate and multivariate associations between psychological factors and QoL in patients with ALS (Continued)
Spiritual well-being SWBS5 total Global QoL MQOL total 0.08 [16] 5.0
SWBS5 total MQOL total 3–4 mo F.U. 0.08
SWBS5 total MQOL total 6–8 mo F.U. 0.17
SWBS5 total MQOL total 9–12 mo F.U. −0.12
SWBS5 total MQOL total 12–16 mo F.U. 0.54**
Mindfulness
Mindfulness LMS Global QoL MQOL Single Item Score nr β = 0.06*** [29] 6.5
Mindfulness x time LMS MQOL Single Item Score over 4 mo nr β = 0.009
Coping
Positive coping strategies MNDCS1 HRQoL WHOQoL-BREF total 0.46** β = 0.35*** [37] 7.0
Distraction Brief COPE SF-36 PCS/SF-36 MCS 0.08P −0.11M [46] 4.0
Active coping Brief COPE SF-36 PCS/SF-36 MCS −0.16P 0.11M
Denial Brief COPE SF-36 PCS/SF-36 MCS −0.15P 0.23M
Emotional support Brief COPE SF-36 PCS/SF-36 MCS 0.38P* 0.10M
Instrumental support Brief COPE SF-36 PCS/SF-36 MCS −0.31P −0.02M
Disengagement Brief COPE SF-36 PCS/SF-36 MCS 0.16P 0.33M
Venting Brief COPE SF-36 PCS/SF-36 MCS −0.10P −0.38*M
Positive reframing Brief COPE SF-36 PCS/SF-36 MCS −0.22P 0.32M
Planning Brief COPE SF-36 PCS/SF-36 MCS −0.23P 0.11M
Acceptance Brief COPE SF-36 PCS/SF-36 MCS −0.18P 0.23M
Humor Brief COPE SF-36 PCS/SF-36 MCS −0.15P 0.25M
Self-blame Brief COPE SF-36 PCS/SF-36 MCS 0.11P −0.24M
Substance use Brief COPE SF-36 PCS/SF-36 MCS 0.26P −0.44*M
Problem management MNDCS2 Global QoL SEIQoL index score β = 0.44** [36] 6.0
Problem management MNDCS2 SEIQoL index score 3-6 mo F.U. nr β = 0.42** [30] 6.0
Problem appraisal MNDCS2 SEIQoL index score nr β = 0.15 [36] 6.0
Emotion management MNDCS2 SEIQoL index score nr β = −0.26
Emotional avoidance MNDCS2 SEIQoL index score nr β = 0.39*
Emotional avoidance MNDCS2 SEIQoL index score 3–6 mo F.U. nr β = 0.28 [30] 6.0
Hopelessness BHS Global QoL Single-item-question3 0.43*** s**/nr [45] 5.5
Perception of burden to others ZBI - revised Global QoL Single-item-question3 0.45*** s*/nr [45] 5.5
Cognitive appraisal




















Table 6 Results of the bivariate and multivariate associations between psychological factors and QoL in patients with ALS (Continued)
Primary appraisal Appraisal scale SEIQoL index score nr β = −0.004
Appraisal of coping potential Appraisal scale SEIQoL index score nr β = 0.15
PERSONALITY Agreeableness NEO-FFI Global QoL Single-item-question4 nr β = 1.88* [27] 4.0
Agreeableness NEO-FFI HRQoL HRCS nr β = 0.69*
Agreeableness x time NEO-FFI Global QoL Single-item-question4 over 12 mo nr β = −0.28*
Agreeableness x time NEO-FFI HRQoL HRCS over 12 mo nr β = −0.09*
Neuroticism NEO-FFI Global QoL Single-item-question4 nr ns/nr
Extraversion NEO-FFI Single-item-question4 nr ns/nr
Openness NEO-FFI Single-item-question4 nr ns/nr
Conscientiousness NEO-FFI Single-item-question4 nr ns/nr
Note. Significance levels: *p < 0.1; **p < 0.01; ***p < 0.001
Abbreviations: ns not significant, nr not reported, r correlation, β standardized regression coefficient, R2 explained variance of the determinant, D diagnosis, A obtained from the author, F.U. follow-up, 1 modified version 1, 2
modified version 2, 3 self-developed single-item-question by Ganzini, 4 self-developed single-item-question by Krampe, 5 SWBS developed by Reed [51], 6 SWBS developed by Ellison [52], HRCS health-related QoL composite
score, PCS physical component summary (P), MCS mental component summary (M), T0 data from baseline measurement, O overall (both < 1 month after diagnosis and > 1 month after diagnosis); Abbreviations of measurements:




















The second study [16] showed that spirituality (which
refers to a search for the sacred or divine through any
type of life experience) was strongly associated (0.54)
with higher global QoL at long-term follow-up (12–16
months) but not at the earlier assessments.
Mindfulness
One recent high quality study found a positive association
between mindfulness ‘the process of actively making new
distinctions about a situation and its environment, or its
current context, rather than relying on previous categori-
zations from the past’ [48] and global QoL [29]. The
results of a linear mixed model analysis showed that high
mindfulness at baseline predicted significantly higher
global QoL scores after four months [29].
Coping
Four studies, including three high quality studies, in-
vestigated the associations between coping and QoL
[30, 36, 37, 46], in which two studies reported
HRQoL and two studies global QoL measures.
One high quality study out of two showed that ‘adoption
of positive coping strategies’ was moderately positively
(0.46) associated with HRQoL [37]. The second study [46]
related 14 coping strategies to HRQoL (36-item Short
Form (SF36); Mental Component Summary score (MCS)
and Physical Component Summary scores (PCS)). Of
these 28 bivariate correlations, three were significantly
associated: negative, moderate correlations were noted
between MCS and substance use (−0.44) and between
MCS and venting (an externalizing coping technique, the
outward expression of emotions) (−0.38). PCS was posi-
tively, moderately associated with emotional support (0.38).
The other 11 coping strategies (e.g. acceptance, denial, self-
blame) were not associated with HRQoL [46].
Two high quality studies, analyzing the same cohort,
showed that the coping strategy ‘problem management’
was positively associated with global QoL. The first
study [36] with a cross-sectional design, using multivari-
ate regression analysis, revealed positive associations be-
tween the coping strategy ‘problem management’ and
‘emotional avoidance’ and global QoL at baseline [30].
Analysis of a longitudinal follow-up [30] revealed that
only the coping strategy ‘problem management’ was a
significant predictor; patients who searched more fre-
quently for information and support at baseline reported
higher global QoL at 3 to 6 months’ follow-up [30].
Hopelessness
One study tested the association of hopelessness and
global QoL [45]. It was shown that greater hopelessness
was moderately correlated with lower global QoL (0.43).
This relationship was still significant in a multivariate
regression analysis with control variables.
Perception of burden to others
A single study examined the ‘perception of burden to
others’. Having the belief of being a burden to others
was moderately associated with lower global QoL (0.45).
The association remained significant in the regression
analyses [45].
Cognitive appraisal
A single study [36] assessed ‘cognitive appraisal’, which
was split into patient’s primary (motivational relevance,
motivational congruence) and secondary appraisal (prob-
lem focused and emotional focused coping potential) and
related to global QoL. Results of the regression analysis
showed no associations of cognitive appraisal with global
QoL. The variance of the global QoL scores could not be
significantly accounted for by any of the appraisals scales.
Personality associated with QoL
Neuroticism, extraversion, openness, agreeableness and
conscientiousness
One study [27] investigated the relationship between per-
sonality factors and QoL. In the regression analysis, it was
shown that among the five personality factors (neuroticism,
extraversion, openness, agreeableness and conscientious-
ness), only agreeableness had a strong positive association
with both global QoL and HRQoL. Agreeableness refers to
‘a personality trait manifesting itself in individual behav-
ioral characteristics that are perceived as kind, sympathetic,
cooperative, warm and considerate’ [49]. There was also a
significant interaction effect of agreeableness and time,
meaning that agreeableness significantly influenced the
course of global QoL and HRQoL; patients who scored
higher on agreeableness had higher QoL ratings at baseline
measurement but their decline in QoL was steeper com-
pared to patients with lower scores in agreeableness [27].
Discussion
The aim of the present review was to systematically collect
and appraise evidence of the relationships between
psychological factors (mood, beliefs, personality) and QoL
in patients with ALS. This review showed that higher
levels of anxiety and depression appeared to be related to
a poorer HRQoL, whereas a higher level of religiosity
seemed to be related to higher global QoL. Furthermore,
associations might change during the disease course.
Mood
Anxiety seemed to be negatively related to HRQoL, be-
cause higher levels of anxiety were consistently associ-
ated with a poorer HRQoL. In contrast, global QoL
showed no associations with anxiety; the association
could not, however, be refuted because of one poor
quality study. Depression was negatively associated
with HRQoL, suggesting that the presence of depressive
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symptoms is related to a poorer HRQoL. On the other
hand, for global QoL, we could not support a relation-
ship with depression, because of inconsistent results.
Mood appeared to be related to HRQoL but not to
global QoL. This is in concurrence with cancer studies
[9, 50], which also revealed that depression explained a
large amount of variation in HRQoL, but not global
QoL. Our results might in part be ascribed to conceptual
overlap [51] between determinants and outcomes. For
example, questions about feelings of anxiety and de-
pression are often also included in a HRQoL measure
(e.g. “Have you felt downhearted and blue?” SF-36;
question 9f [52]), and so studying anxiety and depres-
sion as determinants of HRQoL may result in strong
associations between determinants and outcomes.
This contamination is less likely between mood and
global QoL measures, because global QoL assesses
such a wide spectrum of domains that contribute to
overall QoL as judged by the patient.
Furthermore, it is important to be aware that there
is recent evidence suggesting that depression ques-
tionnaires, specifically the Beck Depression Inventory
(BDI) [53] and to a lesser degree the Hospital Anxiety
and Depression Scale (HADS) [54], tend to overesti-
mate depression in ALS, since these scores are highly
influenced by the physical impairment of the patients
[55, 56]. Consequently, the relationships that have been
found between depression and HRQoL is questionable.
Beliefs
There seemed to be no relationship between religiosity and
HRQoL, because most studies showed weak and non-
significant associations. However, religiosity appeared to be
positively associated with global QoL in the majority of the
studies, including one high quality study. Consequently, we
support the assumption that a high level of religiosity made
a significant positive contribution to better global QoL.
However, these results might also point out to contamin-
ation in concepts between religiosity and global QoL since
the The McGill Quality of Life Questionnaire (MQOL)
total score includes items about existential well-being.
Religiosity might be important for the individual’s glo-
bal QoL because it may create meaning and coherence
when an individual’s world is devastated by a distressing
and progressive disease [47]. These findings are mirrored
in other diseases such as Multiple Sclerosis [57] and
advanced cancer [58]. It should be taken into account
that most of the included studies about religiosity are
from North America and the religiosity questionnaire
which was used relies predominantly on monotheistic
terminology, about belief in God or experience of God
[59]. In current (western) culture, people are more in-
terested in spirituality [60] and mindfulness [55] and
are searching for a connection with the divine within
themselves, instead of a connection with an external al-
mighty power [60]. The fact that religiosity and spirituality
are culture dependent and are defined differently in each
country might explain the heterogeneity in findings on
association of QoL.
Personality
The search has yielded only one hit concerning personality
factors, suggesting that personality factors were not
considered to be the most important psychological fac-
tors influencing QoL. Only a single study of low quality
was included, conclusive associations between HRQoL
or global QoL could, therefore, not be established.
Miscellaneous
Several other psychological factors were reported in only
a single study or measured twice in the same cohort [30,
36]: there was, therefore, insufficient evidence to support
associations between HRQoL or global QoL and the
following psychological factors: confusion-bewilderment
(mood); spirituality, mindfulness, coping styles, hopeless-
ness, perception of burden, cognitive appraisal (beliefs)
and neuroticism, extraversion, openness, agreeableness
and conscientiousness (personality).
Associations throughout the disease course
Although there was not enough evidence per psycho-
logical factor, it is valuable to point out with regard to
psychological factors as a whole, that associations might
change throughout the course of the disease; religiosity
and spirituality appeared to become more positively
associated with global QoL over time. This is in accord-
ance with the theory of Waldron [61] who suggested
that psychological adaptation to terminal illness may
involve a shift in focus of determinants of QoL; in the
initial stages of a progressive illness, patients may focus
on physical functioning and on decreasing disability, but
as the illness progresses, the importance of these issues
may be replaced by a focus on the psychosocial and
spiritual domains.
Strengths and limitations of this systematic review
This is the first systematic review on associations between
psychological factors and QoL in patients with ALS. This
review was carried out in accordance with the PRISMA
guidelines (see online Additional file 1). The methodo-
logical quality of the studies and the consistency of the
associations between psychological factors and HRQoL
and global QoL were comprehensively appraised. A limita-
tion, however, of our study is that only a small number of
psychological factors could be compared, because most of
the associations with QoL were only reported once.
Besides, our review may have missed relevant papers
published in non-English journals. Finally, as studies with
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significant results are more likely to be published than
studies without significant results, publication bias has to
be taken into account.
Limitations of the literature
First, the heterogeneity of the literature with respect to
instruments for assessing psychological factors and QoL
may have influenced the associations. Levels of anxiety
and depression, for example, were measured using 5 and
7 different questionnaires, respectively, and moreover,
with a mix of both generic and ALS-specific question-
naires, or questionnaires modified for ALS. Concerning
QoL measures, 7 different HRQoL and 5 different global
QoL (mostly generic) measures, were extracted. Second,
in order to detect which psychological factors affect
HRQoL and global QoL over the course of the disease,
it is essential to cluster the data of patients according to
the same disease stage (diagnostic stage, rehabilitation
stage and terminal stage [62]). In fact, only one study
analyzed the determinants of patients in the diagnostic
phase separately [41]. Other longitudinal studies only
reported changing associations of depression, coping,
religiosity and personality factors after baseline meas-
urement, without specific information about the disease
stage. Other limitations concern studies with a cross-
sectional design and the overrepresentation of small
studies, without an adequate sample size in relation to
the number of determinants.
Conclusions, clinical implications and further
research
Our results suggest that higher levels of anxiety and de-
pression are related to a poorer HRQoL, whereas higher
levels of religiosity appeared to be related to better global
QoL. Furthermore, associations might change throughout
the disease course.
Therefore it is important for health professionals to
become aware of the relationships between psychological
factors and QoL, as these relationships identify possible
targets for interventions to improve QoL. It seems rele-
vant for health professionals in ALS care, to focus on in-
fluencing mood and beliefs in order to improve HRQOL
and global QoL. Furthermore, it is relevant to make a
distinction between HRQoL and global QoL, because
HRQoL is expected to decline, according to a decrease
in mental and physical functioning, whereas global QoL
seems more dependent on other factors, such as existen-
tial concerns.
More high quality research is needed to confirm the
assumed association between anxiety, depression and
religiosity and HRQoL and global QoL and to investi-
gate how and when these factors can be targeted in
ALS care. Coping, spirituality, mindfulness, hopeless-
ness, perception of burden and agreeableness might be
other promising factors that influence QoL, but war-
ranted further investigation. More longitudinal studies
in larger samples are needed because they allow causal
relationships and effects of time to be identified.
Furthermore, uniformity of measures for QoL and psy-
chological factors, preferably ALS-specific, are required
in order to obtain reliable, comparable data. As small
sample sizes are inherent to ALS research, the answer
may lie in international collaboration and data gathered
by online survey.
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